Skip to main content

Table 2 The radiological, anthropometric and biological data overall and in all groups

From: Can visceral adipose tissue and skeletal muscle predict recurrence of newly diagnosed Crohn’s disease in different treatments

Characteristics

Group A

Group B

Group C

Overall

Relapse

29 (50.88%)

Not Relapse

28 (49.12%)

P

Relapse

22 (31.43%)

Not Relapse

48 (68.57%)

P

Relapse

6 (13.64%)

Not Relapse

38 (86.36%)

P

Relapse

57 (33.33%)

Not Relapse

114 (66.67%)

P

Radiological and Anthropometric data

VAT, mean ± sd

51.94 ± 45.52

48.83 ± 43.54

0.495

59.78 ± 42.28

56.73 ± 47.64

0.798

41.20 ± 13.20

31.14 ± 33.22

0.471

54.63 ± 42.50

44.63 ± 42.99

0.152

SAT, mean ± sd

44.81 ± 46.49

66.44 ± 43.89

0.147

48.83 ± 25.64

63.80 ± 39.65

0.110

57.02 ± 36.49

44.25 ± 38.87

0.455

49.68 ± 38.11

57.93 ± 41.28

0.208

MFI, mean ± sd

1.51 ± 0.88

0.63 ± 0.38

0.000

1.32 ± 0.62

1.04 ± 0.97

0.210

1.32 ± 1.32

1.20 ± 1.50

0.858

1.42 ± 0.83

0.99 ± 1.10

0.011

VAT/FM, mean ± sd

0.55 ± 0.13

0.35 ± 0.13

0.000

0.53 ± 0.14

0.44 ± 0.15

0.030

0.46 ± 0.22

0.44 ± 0.18

0.810

0.53 ± 0.14

0.42 ± 0.16

0.000

Visceral obesity, n (%)

 Yes

2 (6.90%)

1 (3.58%)

1.000

1 (4.55%)

4 (8.33%)

0.495

0 (0.00%)

1 (2.63%)

0.864

3 (5.26%)

6 (5.26%)

1.000

 No

27 (93.10%)

27 (96.42%)

 

21 (95.45%)

44 (91.67%)

 

6 (100.00%)

37 (97.37%)

 

54(94.74%)

108 (94.74%)

 

SM, mean ± sd

120.58 ± 25.08

120.08 ± 26.88

0.942

118.05 ± 27.32

115.97 ± 26.85

0.765

112.48 ± 26.80

121.90 ± 27.50

0.438

118.75 ± 25.78

118.95 ± 26.96

0.963

SMI, mean ± sd

42.32 ± 6.55

43.08 ± 8.18

0.699

41.05 ± 8.10

41.76 ± 7.75

0.728

40.19 ± 8.09

42.63 ± 8.15

0.498

41.60 ± 7.25

42.37 ± 7.94

0.540

Sarcopenia, n (%)

 Yes

29 (100.00%)

25 (89.29%)

0.112

21 (95.45%)

42 (87.50%)

0.287

6 (100.00%)

33 (86.84%)

0.462

56 (98.25%)

100 (87.72%)

0.022

 No

0 (0.00%)

3 (10.71%)

 

1 (4.55%)

6 (12.50%)

 

0 (0.00%)

5 (13.16%)

 

1 (1.75%)

14 (12.28%)

 

BMI*, mean ± sd

18.83 ± 2.65

19.50 ± 2.94

0.370

18.81 ± 2.83

19.24 ± 2.61

0.532

18.85 ± 2.21

18.69 ± 2.80

0.900

18.83 ± 2.64

19.12 ± 2.75

0.498

Standard body weight

 Underweight

15 (51.72%)

13 (46.43%)

0.290

11 (50.00%)

22 (45.83%)

1.000

2 (33.33%)

18 (47.37%)

0.751

28 (49.12%)

53 (46.49%)

0.180

 Normal BMI

14 (48.28%)

12 (42.86%)

 

11 (50.00%)

24 (50.00%)

 

4 (66.67%)

18 (47.37%)

 

29 (50.88%)

54 (47.37%)

 

 Overweight

0 (0.00%)

3 (10.71%)

 

0 (0.00%)

2 (4.17%)

 

0 (0.00%)

2 (5.26%)

 

0 (0.00%)

7 (6.14%)

 

Biological data

ESR, mean ± sd

37.89 ± 28.71

27.41 ± 34.02

0.227

36.35 ± 31.51

47.46 ± 35.83

0.233

29.83 ± 13.36

45.89 ± 34.99

0.062

36.40 ± 28.25

42.22 ± 35.90

0.264

High ESR, n (%)

 Yes

17 (62.97%)

9 (34.62%)

0.039

13 (65.00%)

37 (74.00%)

0.231

5 (83.33%)

24 (70.59%)

0.464

35 (66.04%)

70 (64.81%)

0.878

 No

10 (37.04%)

17 (65.38%)

 

7 (35.00%)

11 (26.00%)

 

1 (16.67%)

10 (29.41%)

 

18 (33.96%)

38 (35.19%)

 

CRP, mean ± sd

42.75 ± 65.49

20.78 ± 43.23

0.167

25.86 ± 28.15

29.34 ± 34.81

0.706

42.01 ± 44.07

39.00 ± 53.50

0.897

36.82 ± 52.82

30.66 ± 43.77

0.437

High CRP, n (%)

 Yes

25 (89.29%)

12 (50.00%)

0.002

11 (61.11%)

34 (70.83%)

0.319

5 (83.33%)

26 (72.22%)

0.497

41 (78.85%)

72 (66.67%)

0.113

 No

3 (10.71%)

12 (50.00%)

 

7 (38.89%)

14 (29.17%)

 

1 (16.67%)

10 (27.78%)

 

11 (21.15%)

36 (33.33%)

 

Platelet counts, mean ± sd

345.03 ± 179.27

289.79 ± 106.09

0.162

309.00 ± 124.37

348.35 ± 143.18

0.288

363.33 ± 99.92

333.16 ± 115.17

0.548

333.93 ± 153.05

328.90 ± 126.91

0.822

High platelet counts, n (%)

 Yes

27 (93.10%)

26 (92.86%)

1.000

18 (90.00%)

47 (97.92%)

0.205

6 (100.00%)

35 (92.11%)

0.637

51 (92.73%)

108 (97.74%)

0.730

 No

2 (6.90%)

2 (7.14%)

 

2 (10.00%)

1 (2.08%)

 

0 (0.00%)

3 (7.89%)

 

4 (7.27%)

6 (5.26%)

 

Albumin**, mean ± sd

32.20 ± 6.49

35.74 ± 5.46

0.033

34.16 ± 6.42

35.22 ± 6.45

0.536

30.70 ± 7.86

34.08 ± 4.69

0.144

32.77 ± 6.59

34.97 ± 5.67

0.028

Low albumin, n (%)

 Yes

25 (92.59%)

21 (75.00%)

0.143

15 (75.00%)

38 (79.19%)

0.467

6 (100.00%)

33 (86.84%)

0.462

46 (86.79%)

92 (80.70%)

0.333

 No

2 (7.41%)

7 (25.00%)

 

5 (25.00%)

10 (20.83%)

 

0 (0.00%)

5 (13.16%)

 

7 (13.21%)

22 (19.30%)

 
  1. VAT Visceral adipose tissue, SAT subcutaneous adipose tissue, MFI mesenteric fat index, VAT area/FM the ratio of visceral adipose tissue to fat mass, BMI body mass index
  2. *Underweight, BMI < 18.5 kg/m2; Normal BMI, 18.5 ≤ BMI < 24.0; Overweight, 24.0 ≤ BMI < 28.0
  3. **Some patients with missing biological data were not analyzed
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us